RS Research Inc.

Description

Develops polymer-drug conjugate delivery platforms for targeted chemotherapy and theranostics, used to improve therapeutic index for oncology patients and researchers.

Related

• NETRIS PHARMA SASNETRIS Pharma develops first-in-class therapeutics targeting Netrin-1 to overcome resistance in oncology, providing treatments to patients…
• ONK TherapeuticsONK Therapeutics develops ready-made natural killer cell therapies.
• ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…
• Confo TherapeuticsConfo Therapeutics develops small molecule and antibody-based therapeutics using proprietary GPCR-targeting technology for metabolic,…
• Faron Pharmaceuticals Ltd.Develops immunotherapies that leverage patients' immune systems for cancer treatment, serving clinical researchers and healthcare providers…
• Dyno TherapeuticsBuilds high-performance genetic technologies to improve AAV gene delivery for gene therapy, supporting therapeutic developers working on…
• TareBioDevelops vaccines intended for cancer and infectious diseases, addressing needs in oncology and infection prevention or treatment for…
• Incyte ($INCY)Develops and delivers medicines for patients, focusing on hematology, oncology, inflammation, autoimmunity and dermatology, with partnered…
• Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-enabled molecular modeling and drug discovery platforms for use by researchers and partners…
• Numab TherapeuticsNumab Therapeutics engineers multispecific antibodies. Its work supports a therapeutic pipeline based on antibody engineering and Swiss…
• Tessera TherapeuticsDevelops Gene Writing technology and non-viral delivery methods to make targeted genome alterations for therapies addressing major unmet…
• Camurus ABDevelops innovative, long-acting treatments for severe and chronic diseases; used by patients and healthcare systems addressing unmet…